The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Dec. 21, 2021

Filed:

Mar. 15, 2017
Applicant:

Tsumura & Co., Minato-ku, JP;

Inventor:

Mitsue Nishiyama, Ibaraki, JP;

Assignee:

TSUMURA & Co., Minato-ku, JP;

Attorney:
Primary Examiner:
Int. Cl.
CPC ...
C12Q 1/06 (2006.01); C12Q 1/689 (2018.01); G01N 33/48 (2006.01); C12Q 1/02 (2006.01); C12Q 1/68 (2018.01); C12Q 1/24 (2006.01); C12N 1/20 (2006.01);
U.S. Cl.
CPC ...
C12Q 1/06 (2013.01); C12Q 1/02 (2013.01); C12Q 1/025 (2013.01); C12Q 1/24 (2013.01); C12Q 1/68 (2013.01); C12Q 1/689 (2013.01); G01N 33/48 (2013.01); C12N 1/20 (2013.01); C12Q 2545/101 (2013.01);
Abstract

Provided are a method for predicting the effect of Daikenchuto, a method for determining the dosage of Daikenchuto, etc. using an objective index by a method for predicting the effectiveness of Daikenchuto in a patient characterized by including the following steps (a) and (b): (a) a step of determining the ratio of the phylum Bacteroidetes to the phylum Firmicutes (B/Fratio) in the intestine of the patient by analyzing the intestinal flora of the patient; and (b) a step of determining the effectiveness of Daikenchuto in the patient by comparison with criteria such that when the B/Fratio is lower than a reference value, Daikenchuto is more effective, and when the B/Fratio is higher than a reference value, Daikenchuto is less effective, and a method for determining the dosage of Daikenchuto for a patient characterized by including the following steps (a) and (e): (a) a step of determining the ratio of the phylum Bacteroidetes to the phylum Firmicutes (B/Fratio) in the intestine of the patient by analyzing the intestinal flora of the patient, and (e) a step of determining the dosage of Daikenchuto for the patient by decreasing the dosage of Daikenchuto for the patient when the B/Fratio determined in the step (a) is a lower value than a reference value, and increasing the dosage of Daikenchuto for the patient when the B/Fratio is a higher value than a reference value.


Find Patent Forward Citations

Loading…